Tag: lung
Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What...
Merck’s Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent...
Imfinzi maker AstraZeneca’s ‘Notes’ campaign delivers encouragement to lung cancer patients
Lung cancer diagnosis and treatment are tough enough in the best of times. AstraZeneca’s new campaign aims to help patients going through both, at a...
Watch out, Merck: FDA grants Regeneron, Sanofi’s Libtayo priority review for...
One month after Regeneron and Sanofi posted impressive data from a phase 3 trial of their PD-1 inhibitor Libtayo in first-line non-small cell lung...
Bristol Myers’ Opdivo clears signs of lung cancer in first-in-class pre-surgery...
Bristol Myers Squibb’s Opdivo may not be the most popular immunotherapy for treating metastatic non-small cell lung cancer, but it’s now the first to report...
ASCO: AstraZeneca’s Tagrisso, headed for big sales boost, cuts lung cancer...
In mid-April, at the recommendation of an independent data monitoring committee, AstraZeneca unblinded a phase 3 trial of Tagrisso two years early. Now, the...
Veran Medical introduces navigated catheter for lung cancer lesions
Veran Medical has introduced a new navigated catheter and two navigation software applications to help physicians diagnose and guide treatment of early-stage lung cancer...
